Rocuronium
Rocuronium
Nondepolarizing Neuromuscular Blocker
NADAC/unit
$0.3942
Active Shortage
18 Manufacturers
35 ANDAs
vs. brand Rocuronium: Generic saves up to 96% per unit
Active Shortages
2023-02-15 Check wholesalers for inventory, Fresenius Kabi USA, LLC
2023-02-15 Check wholesalers for inventory, Fresenius Kabi USA, LLC
2023-02-15 Shortage reported, Meitheal Pharmaceuticals, Inc.
2023-02-15 Shortage reported, Mylan Institutional, a Viatris Company
2023-02-15 Next release not available at this time. Check wholesaler for inventory., Fresenius Kabi USA, LLC
Market Intelligence
2024-03-20 Class II Recall: Mckesson Medical-Surgical Inc. Corporate Office
Generic Manufacturers
ASPIRO PHARMA LTDB BRAUN MEDICAL INCCAPLIN STERILES LTDEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHOSPIRA INCKNACK PHARMACEUTICALS INCMANKIND PHARMA LTDMEITHEAL PHARMACEUTICALS INCMYLAN INSTITUTIONAL LLCPIRAMAL CRITICAL CARE INCPRINSTON PHARMACEUTICAL INCSAGENT PHARMACEUTICALS INCSANDOZ INCSHANDONG NEW TIME PHARMACEUTICAL CO LTDSTERISCIENCE PTE LTDTAMARANG SAWEST WARD PHARMACEUTICAL CORP
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.